Karen Ding practices complex commercial litigation, managing all aspects of a case for a wide variety of clients.
During law school, Ms. Ding served as the senior articles editor and member of the board of the Stanford Law Review and worked as a research assistant to Professors Michael Wald, Debbie Mukamal, Michelle M. Mello and David Studdert. She also served as a law student intern to the United States Attorney’s Office in Chicago.
Prior to law school, Ms. Ding was a consultant at The Boston Consulting Group, where she handled a number of projects including analyzing global supply chain operations for a Japanese pharmaceutical company, conducting primary consumer research to develop a new pricing strategy for a major global fast-food chain, creating progress tracking metrics for the UN Mission for Emergency Ebola Response, and serving as a project manager for implementation of distributor engagement strategy for a U.S. beer supplier.
Won “landmark” opioid trial for Endo Pharmaceuticals in a closely watched $50 billion California case alleging public nuisance, unfair competition, and false advertising. Obtained a full defense verdict following a four-month trial. The win was hailed as “giv[ing] drug companies their first major victory in the litigation brought by cities and counties across the country over the opioid crisis,” American Lawyer. (See “How Hueston Hennigan Notched A Landmark Opioid Trial Win,” Law360; “Opioid Makers Win Major Victory in California Trial,” New York Times; “Drug Makers Handed First Win Out of Thousands of National Opioid Crisis Lawsuits,” Newsweek).
Representing Ring (an Amazon.com, Inc. subsidiary) in class action lawsuits filed against it arising out of alleged hacking of Ring devices.
Represent a major laboratory in a HHS-OIG investigation of billing and compensation practices related to the Anti-Kickback Statute and the False Claims Act.
Representing the California Institute of Technology in a False Claims Act lawsuit alleging that the Institute defrauded the Department of Energy out of millions of dollars in government funds associated with a renewable energy research program.